In turn, miR-200b directly represses expression of the HIF1A mRNA to form a HIF1A-ASCL2-miR-200 feedback loop that contributes to the ability of CRC cells to switch between EMT and MET [62]. The gene discussed is ASCL2; the disease is colorectal carcinoma.